• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

万古霉素耐药屎肠球菌和万古霉素耐药粪肠球菌菌血症相关临床特征和结局的比较。

Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.

机构信息

Division of Infectious Diseases, Wayne State University, Detroit Medical Center, Detroit, Michigan, USA.

出版信息

Antimicrob Agents Chemother. 2012 May;56(5):2452-8. doi: 10.1128/AAC.06299-11. Epub 2012 Feb 21.

DOI:10.1128/AAC.06299-11
PMID:22354290
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3346609/
Abstract

In published studies, cohorts of patients with bacteremia due to vancomycin-resistant Enterococcus (VRE) have predominantly been infected with Enterococcus faecium. Little is known about the epidemiology and outcomes associated with bacteremia due to VR Enterococcus faecalis. A retrospective study of isolates obtained from January 2008 to October 2010 was conducted at Detroit Medical Center (DMC). Unique patients with blood cultures positive for VRE were reviewed. Outcomes were analyzed using logistic regression. During the study period, 105 cases of bacteremia due to VR E. faecalis and 197 cases of bacteremia due to VR E. faecium were identified. The mean age in the study cohort was 61.5 ± 15 years; 162 subjects (53.6%) were male. After controlling for a propensity score, bacteremia due to VR E. faecalis was associated with >2-fold-lower in-hospital mortality than bacteremia due to VR E. faecium. Interestingly, bacteremia due to VR E. faecalis was associated with longer hospital stay after VRE isolation, although total length of stay was similar for groups with VR E. faecalis and VR E. faecium. Bacteremia due to VR E. faecalis was associated with a >2-fold-lower risk for mortality than bacteremia due to VR E. faecium, possibly due to the availability of β-lactam therapeutics for treatment of VR E. faecalis.

摘要

在已发表的研究中,耐万古霉素肠球菌(VRE)菌血症患者队列主要感染粪肠球菌(Enterococcus faecium)。对于屎肠球菌(Enterococcus faecalis)引起的菌血症的流行病学和结局知之甚少。在底特律医疗中心(DMC)进行了一项回顾性研究,研究对象为 2008 年 1 月至 2010 年 10 月期间获得的分离株。对血培养阳性的 VRE 独特患者进行了回顾性分析。使用逻辑回归分析了结局。在研究期间,共发现 105 例屎肠球菌引起的菌血症和 197 例粪肠球菌引起的菌血症。研究队列的平均年龄为 61.5 ± 15 岁;162 名患者(53.6%)为男性。在控制倾向评分后,与粪肠球菌引起的菌血症相比,屎肠球菌引起的菌血症的院内死亡率降低了两倍以上。有趣的是,在 VRE 分离后,屎肠球菌引起的菌血症与更长的住院时间相关,尽管屎肠球菌和粪肠球菌组的总住院时间相似。与粪肠球菌引起的菌血症相比,屎肠球菌引起的菌血症的死亡率降低了两倍以上,这可能是由于治疗屎肠球菌的β-内酰胺类药物的可用性。

相似文献

1
Comparison of the clinical characteristics and outcomes associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant E. faecium bacteremia.万古霉素耐药屎肠球菌和万古霉素耐药粪肠球菌菌血症相关临床特征和结局的比较。
Antimicrob Agents Chemother. 2012 May;56(5):2452-8. doi: 10.1128/AAC.06299-11. Epub 2012 Feb 21.
2
Outcomes for and risk factors associated with vancomycin-resistant Enterococcus faecalis and vancomycin-resistant Enterococcus faecium bacteremia in cancer patients.癌症患者中耐万古霉素粪肠球菌和耐万古霉素屎肠球菌菌血症的转归及相关危险因素
Infect Control Hosp Epidemiol. 2007 Sep;28(9):1054-9. doi: 10.1086/519932. Epub 2007 Jul 12.
3
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.耐万古霉素肠球菌血症:粪肠球菌和屎肠球菌临床特征及结局的比较
J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.
4
The importance of adjusting for enterococcus species when assessing the burden of vancomycin resistance: a cohort study including over 1000 cases of enterococcal bloodstream infections.评估万古霉素耐药性负担时调整肠球菌种属的重要性:一项包括 1000 多例肠球菌血流感染病例的队列研究。
Antimicrob Resist Infect Control. 2018 Nov 14;7:133. doi: 10.1186/s13756-018-0419-9. eCollection 2018.
5
Impact of different antimicrobial therapies on clinical and fiscal outcomes of patients with bacteremia due to vancomycin-resistant enterococci.不同抗菌治疗对耐万古霉素肠球菌所致菌血症患者临床及经济结局的影响。
Antimicrob Agents Chemother. 2014 Jul;58(7):3968-75. doi: 10.1128/AAC.02943-14. Epub 2014 May 5.
6
Prevalence, outcome and risk factor associated with vancomycin-resistant Enterococcus faecalis and Enterococcus faecium at a Tertiary Care Hospital in Northern India.印度北部一家三级护理医院中与耐万古霉素粪肠球菌和屎肠球菌相关的患病率、结局及危险因素。
Indian J Med Microbiol. 2016 Jan-Mar;34(1):38-45. doi: 10.4103/0255-0857.174099.
7
Single center experience of a vancomycin resistant enterococcal endocarditis cohort.单中心万古霉素耐药肠球菌性心内膜炎队列的经验。
J Infect. 2011 Dec;63(6):420-8. doi: 10.1016/j.jinf.2011.08.014. Epub 2011 Sep 6.
8
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia--a five-year retrospective review.万古霉素敏感屎肠球菌和粪肠球菌菌血症患者的临床特征和结局——一项五年回顾性研究。
Eur J Clin Microbiol Infect Dis. 2010 Jan;29(1):107-14. doi: 10.1007/s10096-009-0830-5. Epub 2009 Nov 15.
9
A 10-year profile of enterococcal bloodstream infections at a tertiary-care hospital in Japan.日本一家三级护理医院10年的肠球菌血流感染情况概述。
J Infect Chemother. 2017 Jun;23(6):390-393. doi: 10.1016/j.jiac.2017.03.009. Epub 2017 Apr 4.
10
Clinical characteristics and outcomes of patients with vancomycin-susceptible Enterococcus faecalis and Enterococcus faecium bacteraemia in cancer patients.癌症患者中对万古霉素敏感的粪肠球菌和屎肠球菌菌血症患者的临床特征和结局。
Eur J Clin Microbiol Infect Dis. 2011 Jan;30(1):103-8. doi: 10.1007/s10096-010-1029-5. Epub 2010 Aug 15.

引用本文的文献

1
Prevalence of Vancomycin-resistant enterococci (VRE) in Egypt (2010-2022): a systematic review and meta-analysis.埃及耐万古霉素肠球菌(VRE)的流行情况(2010 - 2022年):一项系统评价和荟萃分析
J Egypt Public Health Assoc. 2023 Apr 11;98(1):8. doi: 10.1186/s42506-023-00133-9.
2
Vancomycin Resistance in and .[具体研究对象]中的万古霉素耐药性 以及[具体研究对象]。 你提供的原文信息不完整,我只能按照要求进行这样的翻译。请补充完整原文以便我能给出更准确的译文。
Microorganisms. 2022 Dec 21;11(1):24. doi: 10.3390/microorganisms11010024.
3
Performance Efficiency of Conventional Treatment Plants and Constructed Wetlands towards Reduction of Antibiotic Resistance.传统污水处理厂和人工湿地在降低抗生素耐药性方面的性能效率
Antibiotics (Basel). 2022 Jan 16;11(1):114. doi: 10.3390/antibiotics11010114.
4
Does Vancomycin Resistance Increase Mortality? Clinical Outcomes and Predictive Factors for Mortality in Patients with Infections.万古霉素耐药性会增加死亡率吗?感染患者的临床结局及死亡预测因素
Antibiotics (Basel). 2021 Jan 22;10(2):105. doi: 10.3390/antibiotics10020105.
5
Predictors of Mortality in Patients with Carbapenem-Resistant Gram-Negative Bacilli or Vancomycin-Resistant Enterococci Bacteremia.耐碳青霉烯类革兰阴性杆菌或耐万古霉素肠球菌菌血症患者的死亡率预测因素
Infect Drug Resist. 2020 Oct 9;13:3535-3542. doi: 10.2147/IDR.S269087. eCollection 2020.
6
Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting.万古霉素耐药肠球菌引起的血流感染在万古霉素耐药肠球菌流行地区癌症患者中的流行病学、治疗及转归
BMC Infect Dis. 2020 Mar 18;20(1):228. doi: 10.1186/s12879-020-04952-5.
7
Does vancomycin resistance increase mortality in Enterococcus faecium bacteraemia after orthotopic liver transplantation? A retrospective study.万古霉素耐药是否会增加肝移植术后粪肠球菌菌血症的死亡率?一项回顾性研究。
Antimicrob Resist Infect Control. 2020 Jan 31;9(1):22. doi: 10.1186/s13756-020-0683-3.
8
Enterococcal bacteremia in febrile neutropenic children and adolescents with underlying malignancies, and clinical impact of vancomycin resistance.中性粒细胞减少伴发热的恶性肿瘤患儿和青少年肠球菌菌血症,以及万古霉素耐药的临床影响。
Infection. 2019 Jun;47(3):417-424. doi: 10.1007/s15010-018-1260-z. Epub 2018 Dec 19.
9
Effectiveness of a Lytic Phage SRG1 against Vancomycin-Resistant in Compost and Soil.溶菌噬菌体 SRG1 对堆肥和土壤中耐万古霉素的有效性。
Biomed Res Int. 2017;2017:9351017. doi: 10.1155/2017/9351017. Epub 2017 Sep 24.
10
Vancomycin-Resistant Enterococci and Bacterial Community Structure following a Sewage Spill into an Aquatic Environment.污水泄漏到水生环境后耐万古霉素肠球菌与细菌群落结构
Appl Environ Microbiol. 2016 Aug 30;82(18):5653-60. doi: 10.1128/AEM.01927-16. Print 2016 Sep 15.

本文引用的文献

1
Growing prevalence of vancomycin-resistant Enterococcus faecalis in the region with the highest prevalence of vancomycin-resistant Staphylococcus aureus.在耐万古霉素金黄色葡萄球菌患病率最高的地区,耐万古霉素粪肠球菌的患病率不断上升。
Infect Control Hosp Epidemiol. 2011 Sep;32(9):922-4. doi: 10.1086/661599.
2
Outcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.底特律医疗中心耐碳青霉烯肠杆菌科的结果和遗传相关性。
Infect Control Hosp Epidemiol. 2011 Sep;32(9):861-71. doi: 10.1086/661597.
3
Dissemination of an Enterococcus Inc18-Like vanA plasmid associated with vancomycin-resistant Staphylococcus aureus.肠球菌 Inc18 样 vanA 质粒的传播与万古霉素耐药金黄色葡萄球菌有关。
Antimicrob Agents Chemother. 2010 Oct;54(10):4314-20. doi: 10.1128/AAC.00185-10. Epub 2010 Jul 26.
4
Management of multidrug-resistant enterococcal infections.多重耐药肠球菌感染的管理。
Clin Microbiol Infect. 2010 Jun;16(6):555-62. doi: 10.1111/j.1469-0691.2010.03214.x.
5
Evaluation of risk factors for coinfection or cocolonization with vancomycin-resistant enterococcus and methicillin-resistant Staphylococcus aureus.评估耐万古霉素肠球菌和耐甲氧西林金黄色葡萄球菌合并感染或共同定植的危险因素。
J Clin Microbiol. 2010 Feb;48(2):628-30. doi: 10.1128/JCM.02381-08. Epub 2009 Dec 9.
6
VanA-type vancomycin-resistant Staphylococcus aureus.VanA 型万古霉素耐药金黄色葡萄球菌。
Antimicrob Agents Chemother. 2009 Nov;53(11):4580-7. doi: 10.1128/AAC.00346-09. Epub 2009 Jun 8.
7
Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America.血管内导管相关感染的诊断与管理临床实践指南:美国感染病学会2009年更新版
Clin Infect Dis. 2009 Jul 1;49(1):1-45. doi: 10.1086/599376.
8
NHSN annual update: antimicrobial-resistant pathogens associated with healthcare-associated infections: annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007.国家医疗安全网络年度更新:与医疗保健相关感染有关的抗菌药物耐药病原体:2006 - 2007年向疾病控制和预防中心国家医疗安全网络报告的数据年度总结
Infect Control Hosp Epidemiol. 2008 Nov;29(11):996-1011. doi: 10.1086/591861.
9
CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting.疾病控制与预防中心/国家医疗安全网络(CDC/NHSN)对医疗保健相关感染的监测定义以及急性护理环境中特定类型感染的标准。
Am J Infect Control. 2008 Jun;36(5):309-32. doi: 10.1016/j.ajic.2008.03.002.
10
Vancomycin-resistant enterococcal bacteremia: comparison of clinical features and outcome between Enterococcus faecium and Enterococcus faecalis.耐万古霉素肠球菌血症:粪肠球菌和屎肠球菌临床特征及结局的比较
J Microbiol Immunol Infect. 2008 Apr;41(2):124-9.